Holly Lee
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
-
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
- Hematology 24
- Multiple Myeloma Research and Treatments 21
- Iron Metabolism and Disorders 2
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 10
- Protein Degradation and Inhibitors 6
- Co-authors
- Nizar J. Bahlis (30 shared papers)Paola Neri (29 shared papers)Noémie Leblay (15 shared papers)Sungwoo Ahn (14 shared papers)Jason Tay (12 shared papers)Elie Barakat (11 shared papers)Peter Duggan (11 shared papers)Ranjan Maity (9 shared papers)
- Journals
- Blood (17 papers)Canadian Family Physician (2 papers)Nature Reviews Clinical Oncology (1 paper)Canadian Journal of Kidney Health and Disease (1 paper)Canadian Journal of Emergency Medicine (1 paper)
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
Holly Lee
32 papers receiving 185 citations
Peers
Comparison fields: 5 of 39
- Hematology 100
- Oncology 94
- Nephrology 12
- Radiology, Nuclear Medicine and Imaging 35
- Molecular Biology 99
Countries citing papers authored by Holly Lee
This map shows the geographic impact of Holly Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holly Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holly Lee more than expected).
Fields of papers citing papers by Holly Lee
This network shows the impact of papers produced by Holly Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holly Lee. The network helps show where Holly Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Holly Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 24 | |
| 2 | 2024 | 16 | |
| 3 | 2023 | 14 | |
| 4 | 2018 | 12 | |
| 5 | 2022 | 11 | |
| 6 | 2023 | 10 | |
| 7 | 2023 | 10 | |
| 8 | 2024 | 9 | |
| 9 | 2019 | 9 | |
| 10 | 2017 | 8 | |
| 11 | 2021 | 8 | |
| 12 | 2022 | 8 | |
| 13 | 2019 | 5 | |
| 14 | 2020 | 5 | |
| 15 | 2023 | 5 | |
| 16 | 2022 | 4 | |
| 17 | 2021 | 3 | |
| 18 | 2024 | 3 | |
| 19 | 2022 | 3 | |
| 20 | 2021 | 3 |
About Holly Lee
Holly Lee is a scholar working on Hematology, Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 37 papers that have together received 187 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (21 papers), CAR-T cell therapy research (12 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Peptidase Inhibition and Analysis (7 papers), Protein Degradation and Inhibitors (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and Iron Metabolism and Disorders (2 papers). The work is most often cited by research in Hematology (100 citations), Oncology (94 citations), Nephrology (12 citations), Radiology, Nuclear Medicine and Imaging (35 citations) and Molecular Biology (99 citations). Holly Lee has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Nizar J. Bahlis, Paola Neri, Noémie Leblay, Sungwoo Ahn, Jason Tay, Elie Barakat, Peter Duggan, Ranjan Maity, Christopher J. Doig and Víctor H. Jiménez‐Zepeda. Their work appears in journals such as Blood, Canadian Family Physician, Nature Reviews Clinical Oncology, Canadian Journal of Kidney Health and Disease and Canadian Journal of Emergency Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.